aspiration during anesthesia semaglutide case report 2023 Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk

What happened in medicine this week has real consequences in the OR. 🔬 Swipe to see why: → Ozempic patients and surgery don't mix the way you might think → 30% of

27.67

★★★★☆4.8 (126)

Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia

29.26

★★★★★4.9 (98)

Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study

25.57

★★★★★5.0 (157)

Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes

22.94

★★★★★4.7 (84)

Concerns have been raised about whether the delayed gastric emptying caused by GLP-1–based medications might jeopardize patient safety during procedures that require sedation. A randomized trial takes a closer look

27.33

★★★★★4.9 (203)

🔴 GLP-1 RAs and Anesthesia: 2025 Consensus Update: Patients on GLP-1 receptor agonists (e.g., semaglutide, tirzepatide, dulaglutide) can continue their medications before anesthesia if asymptomatic, with extended fasting to reduce aspiration risk

24.35

★★★★★5.0 (176)

How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like

22.63

★★★★★4.8 (132)